المؤلفون: Muhammad Imran Butt, Quaid Johar Nadri, Abdulmohsen Mohammed Khalid Bakhsh

المصدر: World Journal of Clinical Oncology

مصطلحات موضوعية: 0301 basic medicine, Sorafenib, Oncology, medicine.medical_specialty, medicine.medical_treatment, Nephrotic syndrome, Protein kinase inhibitors, Kidney neoplasms/secondary neoplasm, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Case report, medicine, Polycystic kidney disease, Lenvatinib, Adverse effect, Thyroid cancer, Dialysis, business.industry, medicine.disease, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Vascular endothelial growth factor, Metastasectomy, business, Hurthle cell thyroid cancer, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858df216f0262fcc7268a2cd611b7208
https://doi.org/10.5306/wjco.v12.i4.272